OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
Zahra Torki, Davood Ghavi, Solmaz Hashemi, et al.
Cancer Chemotherapy and Pharmacology (2021) Vol. 88, Iss. 5, pp. 771-793
Closed Access | Times Cited: 13
Zahra Torki, Davood Ghavi, Solmaz Hashemi, et al.
Cancer Chemotherapy and Pharmacology (2021) Vol. 88, Iss. 5, pp. 771-793
Closed Access | Times Cited: 13
Showing 13 citing articles:
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Roberto Mattioli, Andrea Ilari, Beatrice Colotti, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101205-101205
Open Access | Times Cited: 118
Roberto Mattioli, Andrea Ilari, Beatrice Colotti, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101205-101205
Open Access | Times Cited: 118
Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics
Harshita Tiwari, Nilesh Rai, Swati Singh, et al.
Bioengineering (2023) Vol. 10, Iss. 7, pp. 760-760
Open Access | Times Cited: 69
Harshita Tiwari, Nilesh Rai, Swati Singh, et al.
Bioengineering (2023) Vol. 10, Iss. 7, pp. 760-760
Open Access | Times Cited: 69
Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 15
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 15
Interpretable Machine Learning Models to Predict the Resistance of Breast Cancer Patients to Doxorubicin from Their microRNA Profiles
Adeolu Z. Ogunleye, Chayanit Piyawajanusorn, Anthony Gonçalvès, et al.
Advanced Science (2022) Vol. 9, Iss. 24
Open Access | Times Cited: 29
Adeolu Z. Ogunleye, Chayanit Piyawajanusorn, Anthony Gonçalvès, et al.
Advanced Science (2022) Vol. 9, Iss. 24
Open Access | Times Cited: 29
Baicalin and Baicalein Enhance Cytotoxicity, Proapoptotic Activity, and Genotoxicity of Doxorubicin and Docetaxel in MCF-7 Breast Cancer Cells
Joanna Bernasińska, Paweł Hikisz, Anna Pieniążek, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2503-2503
Open Access | Times Cited: 4
Joanna Bernasińska, Paweł Hikisz, Anna Pieniążek, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2503-2503
Open Access | Times Cited: 4
Enhancing Chemosensitivity in Drug-Resistant Breast Cancer Cells Using β-Cyclodextrin-Loaded Quercetin and Doxorubicin Inclusion Complex via Modulating SRC/PI3K/Akt Pathway
Charan Singh Pawar, Karankumar Balamurugan, Sugumar Baskar, et al.
Applied Biochemistry and Biotechnology (2025)
Closed Access
Charan Singh Pawar, Karankumar Balamurugan, Sugumar Baskar, et al.
Applied Biochemistry and Biotechnology (2025)
Closed Access
NSAID-encapsulated nanoparticles as a targeted therapeutic platform for modulating chronic inflammation and inhibiting cancer progression: a review
Srivarshini Sankar, Bharathi Kalidass, Janani Indrakumar, et al.
Inflammopharmacology (2025)
Closed Access
Srivarshini Sankar, Bharathi Kalidass, Janani Indrakumar, et al.
Inflammopharmacology (2025)
Closed Access
Non-coding RNAs in gynecologic cancer
Arezoo Solati, Sina Thvimi, Seyyed Hossein Khatami, et al.
Clinica Chimica Acta (2023) Vol. 551, pp. 117618-117618
Closed Access | Times Cited: 8
Arezoo Solati, Sina Thvimi, Seyyed Hossein Khatami, et al.
Clinica Chimica Acta (2023) Vol. 551, pp. 117618-117618
Closed Access | Times Cited: 8
Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics
Nuzhat Bano, KM Kainat, Mohammad Imran Ansari, et al.
Journal of Chemotherapy (2024), pp. 1-15
Closed Access | Times Cited: 1
Nuzhat Bano, KM Kainat, Mohammad Imran Ansari, et al.
Journal of Chemotherapy (2024), pp. 1-15
Closed Access | Times Cited: 1
Overexpression of miR-490-5p/miR-490-3p Potentially Induces IL-17-Producing T Cells in Patients With Breast Cancer
Farhad Seif, Hajar Vaseghi, Mehdi Ariana, et al.
Meme sağlığı dergisi/Meme sağlığı dergisi (2022) Vol. 18, Iss. 2, pp. 141-147
Open Access | Times Cited: 6
Farhad Seif, Hajar Vaseghi, Mehdi Ariana, et al.
Meme sağlığı dergisi/Meme sağlığı dergisi (2022) Vol. 18, Iss. 2, pp. 141-147
Open Access | Times Cited: 6
Cardioprotective effect of crude polysaccharide fermented by Trametes Sanguinea Lyoyd on doxorubicin-induced myocardial injury mice
Chenjun Shen, Bo Yang, Lili Huang, et al.
BMC Pharmacology and Toxicology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Chenjun Shen, Bo Yang, Lili Huang, et al.
BMC Pharmacology and Toxicology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Protective effect of low-dose radiation on doxorubicin-induced brain injury in mice
Yan Gao, Jingyao Dong, Mengmeng Chen, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 729, pp. 109390-109390
Open Access | Times Cited: 4
Yan Gao, Jingyao Dong, Mengmeng Chen, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 729, pp. 109390-109390
Open Access | Times Cited: 4
Cracking the Code: Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Birandra K. Sinha
(2023)
Open Access | Times Cited: 1
Birandra K. Sinha
(2023)
Open Access | Times Cited: 1
